Mentari Therapeutics ($INM) Spiked 55% on $200M Private Placement — Scored 93/100 at 7:01 AM ET
INM stock spiked 55% after announcing a $200 million private placement. RTPR scored the release 93/100 at 7:01 AM ET.
Mentari Therapeutics (INM) stock is up today after the company announced a $200 million private placement to fund its migraine prevention pipeline, spiking as much as 55% from its price when the release crossed the wire. RTPR assigned the release an impact score of 93/100 at 7:01 AM ET, when the stock traded at $1.98.
What the release announced
According to the press release (free account required), Mentari Therapeutics secured a $200 million private placement earmarked for the company's migraine prevention pipeline development.
What the stock did
Following the announcement, INM traded from $1.98 to a session high of $3.07, a gain of approximately 55%.
The 93/100 impact score placed this release in the 80-100 band, where 49% of releases over the past 90 days produced moves of 15% or more. Most releases in this band did not produce a move of this magnitude.
Historical context
This release received an impact score of 93/100.
- Releases scoring 80-100 produced a 15%+ move 49% of the time.
- Sample size: 180 settled outcomes over the past 90 days.
- Historical observations only, not predictions. Full band-by-band table on the impact scoreboard.
Timeline
- 7:00:03 AM ET — press release crossed the wire
- 7:01:45 AM ET — impact score written: 93/100
- $1.98 — price at publication
- $3.07 — intraday high (55% above the price at publication)
Real-time impact scores on every press release are part of RTPR Pro. Impact scores are in beta; historical tendencies, not predictions or investment advice.